From: Survival analysis and individualized prediction of survival benefit for pancreatic signet ring cell carcinoma: a population study based on the SEER database
Outcomes
SRCC HR (95% CI)
P-value
Overall mortality
Non-adjusted
1.34 (1.21–1.47)
< 0.001
Adjusted
1.18 (1.07–1.30)
Cancer-specific mortality
1.35 (1.22–1.49)
1.19 (1.08–1.31)